Solidsoft Reply Spearheads Ground-breaking Migration of Finland’s National Medicines Verification System
February 01 2024 - 2:30AM
Business Wire
Solidsoft Reply, a Reply Group company specialising in creating
Microsoft Azure cloud-based enterprise solutions, has successfully
migrated Finland's National Medicines Verification System to
its National Blueprint solution. National Blueprint Solution
is Solidsoft Reply's Own National Verification System - A system
built on Microsoft Azure cloud technology to verify medicines in
accordance to the EU Falsified Medicines Directive (FMD). This
notable accomplishment marks a pioneering step for the European
Medicines Verification System (EMVS).
Over four years' worth of data, comprising over 500+ million
medicines pack records, was meticulously migrated. This complex
10-month project required detailed planning and
collaborative engagement with the Finnish Medicines Verification
Organisation (FiMVO). It involved the development of a fully
validated migration toolset, numerous workshops for Finnish IT
suppliers, and documentation on how data is transitioned. This
ensured a secure and seamless transition with full traceability of
its data for auditing purposes.
David Eccles, Partner at Solidsoft Reply, remarked, “This
successful migration is not just a remarkable achievement but also
a testament to our engineering expertise and collaborative ethos at
Solidsoft Reply. Our partnership with FiMVO was instrumental in
overcoming the technical challenges, setting a new standard in the
EMVS ecosystem.”
Maija Gohlke General Manager at the Finnish Medicines
Verification Organisation FiMVO (Suomen Lääkevarmennus Oy) remarked
“the project was handled very professionally and that reflects on
the smooth execution of this project, a first of its kind and of a
huge magnitude, with so many connection points in the supply chain.
The knowledge, dedication and flexibility of the Solidsoft Reply
team exceeded our expectations.”
This marks the first-ever migration of a national medicines
verification system within the EMVS ecosystem between blueprint
providers; and is particularly significant in the context of
healthcare and pharmaceuticals, where accuracy, data integrity, and
security are paramount. This project is a prime example of
Solidsoft Reply’s dedication to enhancing healthcare systems
through advanced technology, significantly contributing to the
safety and efficacy of healthcare delivery.
Reply Reply [EXM, STAR: REY] specialises in the design
and implementation of solutions based on new communication channels
and digital media. Reply is a network of highly specialised
companies supporting key European industrial groups operating in
the telecom and media, industry and services, banking, insurance
and public administration sectors in the definition and development
of business models enabled for the new paradigms of big data, cloud
computing, digital media and the Internet of Things. Reply services
include: Consulting, System Integration and Digital Services.
www.reply.com
Solidsoft Reply Solidsoft Reply is the Reply group
company creating enterprise strength solutions utilising the
Microsoft Azure cloud platform. A global award-winning Microsoft
Solutions Partner, Solidsoft Reply is recognised by the
Pharmaceutical & Healthcare industries as being one the of
leading delivery partners in Verification and Traceability systems
world-wide. www.solidsoft.reply.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240201923213/en/
Press contact:
Reply Fabio Zappelli f.zappelli@reply.com
Tel. +390117711594 Aaron Miani a.miani@reply.com Tel. +44
(0)7769 158787
Reply (BIT:REY)
Historical Stock Chart
From May 2024 to Jun 2024
Reply (BIT:REY)
Historical Stock Chart
From Jun 2023 to Jun 2024